-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $125

Benzinga·10/28/2026 16:08:56
Listen to the news
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $135 to $125.